1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
The Hempshire Group, Inc.

The Hempshire Group, Inc.

HMPSF
The Hempshire Group, Inc.US flagOther OTC
0.19
USD
- -
- -
15.68MMarket Cap
2021 Y
2022 Y
TTM
Revenue per Share
- -
- -
- -
Basic EPS, GAAP
-0.03
-0.1
-0.03
Free Cash Flow per Basic Share
-0.01
-0.05
-0.01
Dividend per Share
- -
- -
- -
Book Value per Share
-0.01
-0.04
-0.05
Tangible Book Value per Share
-0.01
0.02
- -
Basic Weighted Avg Shares
80
66
80
Sales/Revenue/Turnover
- -
- -
- -
Operating Margin (%)
-592.73
-7,107.87
-1,138.21
Depreciation Expense
- -
- -
- -
Net Income, GAAP
-2
-7
-2
Effective Tax Rate (%)
- -
- -
- -
Profit Margin (%)
-755.5
-7,300.91
-1,265.05
Working Capital
-1
1
- -
LT Debt
- -
- -
- -
Total Equity
-1
1
- -
Return on Invested Capital (%)
- -
- -
- -
Return on Capital (%)
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
80
80
80
Market Capitalization
14
14
- -

Working Capital

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
Total Current Assets
1
1
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-219.31%
Free Cash Flow
- -
- -
200.03%
Net Income, GAAP
- -
- -
200.59%
Sales/Revenue/Turnover
- -
- -
-68.89%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
-0.03
2022
-0.01
- -
-0.01
-0.01
-0.1
2023
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Shawn Balaghi
Full Time Employees
8
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
870 E Research Dr Palm Springs CA United States of America 92262
IPO Date
Sep 1, 2022
Website
mountainsmokes.com
Similar Companies
HPGC Renmintongtai Pharmaceutical Corporation (600829.SS)
YourWay Cannabis Brands Inc. (YOUR.CN)
CanSino Biologics Inc. (688185.SS)
Solara Active Pharma Sciences Limited (SOLARA.NS)
Rubicon Organics Inc. (ROMJF)
Sproutly Canada Inc. (SPR.CN)
Business
The Hempshire Group, Inc. (TSXV:HMPG) produces and markets non-tobacco, non-nicotine smokable hemp alternatives under the MOUNTAIN Smokes brand, formulating premium organic products including full-flower hemp smokes in 12 SKUs such as Natural, Mint Squeeze with essence capsule, and Pineapple Squeeze flavors featuring varying cannabidiol (CBD) levels below 0.3% THC; the lineup also incorporates organic mullein, organic sage, and other botanicals in sticks resembling traditional cigarettes for direct-to-consumer sales via its website and select distribution channels. The company offers white-labeling and contract manufacturing services for third-party hemp smoke brands, targets tobacco smokers, CBD users, and health-conscious consumers seeking nicotine-free options, and operates primarily in the United States with international reach in Europe and prior sales in South Africa through logistics partnerships. Headquartered in Calgary, Alberta, Canada, with operational ties to Palm Springs, California, The Hempshire Group resulted from a 2022 business combination with Hoist Capital Corp. and subsequent TSX Venture Exchange listing; recent developments include a 2023 note financing and incentive plan approvals, debt settlements, U.S. performance-based retail partnerships, European Union market entry via exclusive distributors in Belgium, and leadership changes with Shawn Balaghi appointed CEO in 2024 alongside updates to the management team comprising CFO Kevin Bautier and COO Brad Kersch.